Pfizer held to its forecast of $54 billion in Covid related sales this year following stronger-than-expected second quarter earnings and record overall revenues.

“As the Covid pandemic continues to evolve and be highly unpredictable, we must remain vigilant in protecting those who are at greatest risk of getting very sick from Covid," said CEO Albert Bourla.

Jim Cramer cautions that knowing when the bottom has arrived and knowing when to buy back into the market is never easy. Don't risk missing out.

Fighting hidden coronavirus variants is like a whack-a-mole game and this company wants to try a new approach.

Moderna said it now sees sales of Spikevax rising to $19 billion this year, with additional signed options of approximately $3 billion.

Pfizer said combined sales of its Covid vaccine and treatment drugs would rise to $54 billion this year, around half of its total projected revenues.

The U.S. Food & Drug Administration has given its full and final approval for the use of Moderna's 'Spikevax' Covid vaccine, the drugmaker said Monday.

Pfizer is ready to provide 50 million to 100 million vaccine doses for people who are found positive with the omicron variant of the coronavirus if it is needed.

The collaboration will be based on mRNA technology and builds on Pfizer and BioNTech's successful effort to produce a Covid vaccine.

Ford has recently cast a shadow over the auto industry.

Short sellers reversed course and sold $19 billion of shorts in September.

The parent company of Google and Youtube is preparing for a sharp deterioration in the health of the economy.